Page 1,117«..1020..1,1161,1171,1181,119..1,1301,140..»

How to survive the menopause despite UK’s shortage of vital HRT drugs – Mirror Online

Posted: February 27, 2020 at 8:42 am

Every year, one million menopausal women in the UK rely on HRT hormone replacement therapy to help with the symptoms.

But with an ongoing national shortage of the drugs, some women are finding their symptoms return within days.

Others are being forced to switch to different brands or types of HRT which are available in gel, pill or patch form. And they are having side effects.

These include hot flushes, insomnia, exhaustion, loss of sex drive, changes in skin, hair and nails, as well as increased anxiety, weight and depression.

Dr Clarissa Kristjansson left her high-flying career as a neuroscientist after suffering burnout during perimenopause and is now a menopause mentor and mindfulness coach.

She says: Some doctors prescribe HRT. There is nothing wrong with short-term treatment but what happens if youre on it for years?

Here, she looks at alternatives to cope with the menopause.

Also known as dietary estrogen, these compounds are found in certain plants and act in a similar way to the estrogen produced within the body.

Research has linked them to a variety of health benefits, including reduced hot flushes.

The highest concentrations are found in chickpeas, lentils, edamame and soy-based products such as tofu and tempeh. They are also present in wheat bran, broccoli, cauliflower and garlic, as well as some seeds.

Other sources include alfalfa sprouts, mung beans, berries, peaches and dried fruits.

Video Unavailable

Click to playTap to play

Play now

Three-quarters of all hip fractures occur in women. The menopause remains a high-risk factor. Reducing alcohol and excessive caffeine intake, which are known to lead to bone loss, can boost bone health.

Pilates and yoga are effective when combined with weight-training for strengthening and increasing flexibility.

Encourage gut health by adopting a low-acid, plant-based diet, high in calcium and oily fish for omega 3, as well as plenty of magnesium, and vitamins K and D. This combination will allow for the best re-absorption of estrogen otherwise secreted in your bodys waste.

Rhodiala Rosea is proven to help with stress, anxiety and sexual problems associated with menopause. Sage helps combat excessive sweating.

A 2010 review found menopausal women also experienced a 26 per cent reduction in night sweats and hot flushes when using black cohosh supplements.

St Johns Wort is another popular herb that soothes symptoms of low mood and anxiety.

Those seeking a more natural approach to hormone therapy might consider bioidentical HRT hormones identical in molecular structure to those that women make in their bodies, such as 17 beta-estradiol, estrone, and estriol made from yams and soy.

It can be an effective way of restoring hormonal balance, but make sure you consult your doctor first.

1 Set boundaries look at where your energy goes. Whats draining you? Learn to say no.

2. Reduce sugar intake to stabilise blood sugar, thereby helping you sleep better and keep the middle age spread from creeping on.

3. Specialist vaginal moisturisers can relive the dryness, pain, itching and burning often associated with menopause.

4. Stay connected to friends and family. Menopausal women have a tendency to isolate themselves as confidence nosedives and anxiety and depression set in. Forums can be negative spaces, but blogs such as Feeling Flushed and 50 Sense provide a much more grounded and positive dialogue around menopause.

See the original post here:
How to survive the menopause despite UK's shortage of vital HRT drugs - Mirror Online

Posted in Hormone Replacement Therapy | Comments Off on How to survive the menopause despite UK’s shortage of vital HRT drugs – Mirror Online

Want to Transition? There’s an App for That – VICE

Posted: February 27, 2020 at 8:42 am

In plain white text atop a blue-to-pink gradient, Solace greets new users with a dictionary definition of its name: comfort or consolation in a time of distress or sadness. Its a fitting name for an app that aims to give trans people more information about various aspects of transitiona one-stop resource for people who know they are trans, but dont know how to be trans.

After entering some basic informationtheir name, their pronouns, and their location by statethe user is presented with some common transition goals, as Solace terms them. These include all of the major transition milestones like beginning hormone replacement therapy and updating the name and gender marker on ones passport, as well as seemingly mundane (but surprisingly difficult) tasks like buying the right bra.

The goal, according to Solace co-founder Robbi Katherine Anthony, is to help users make their transitions as easy as possiblesomething she wished she could be able to say about her own.

Transition is beautiful, but its also incredibly hard, Anthony told VICE.

Born in New Mexico, the 27-year-old software developer now lives in Spokane, Washington. She came up with the idea and designs Solace with fellow developer Patrick McHugh, and turned to Crowdbotics, a software company in Berkeley, to build out the app. As Solaces only full-time employees, Anthony and McHugh run an extraordinarily lean operation, bouncing between Anthonys home, her 1998 blue Honda CR-V, and whatever coworking space they might be working in on a given day. Its fly or die every single day here, said Anthony. But shes committed to making something that she hopes makes transition a little less confusing, a tool she would have appreciated if it had existed all those years ago.

My transition has been rough, she told VICE. But Ill be damned if I dont do everything in my power to help others avoid that.

Solace co-founders Patrick McHugh (L) and Robbi Katherine Anthony (R). Photo courtesy of Robbi Katherine Anthony.

Anthony said that one of the biggest hurdles she faced in the early stages of her transition was finding out how to transition in the first place. She blamed a lot of this inaccessibility on gatekeeping, a term that, in a trans context, often refers to the many ways in which a health care professional can refuse gender-affirming care to a trans patientsay, a doctor who wont prescribe hormones, or surgeon who wont operate on a woman he doesnt find attractive or cis-passing enough for his standards. Anthony told VICE that she experienced this kind of medical gatekeeping firsthand, but she also used the term to describe her experiences with other trans people.

Certain people in the community become gatekeepers of information, Anthony said. Transition is a model of oral tradition, but if you have to meet people in order to transition, that inherently limits transition to people who can access that network. Some people physically cannot do that or dont want to. That information is also highly anecdotal, which she said is a problem because it ignores how one persons circumstances are not analogous to another persons.

Solace disrupts that model, she continued. If the process could be reduced from finding the right gatekeepers to having a compendium that allows you to proceed on your own terms, I think it would be healthier.

I asked Anthony if creating Solace, an app designed to circumvent community gatekeepers, might turn her into the very trans community gatekeeper she set out to circumvent.

Thats a really fair question, Anthony said. Gatekeeping, in its most nefarious forms, requires folks to do some interaction in order to get information. Whether its being approved by a moderator to join a group, seeking out a time or space or venue based on terms dictated by someone else, or being forced to curry favor with someone for them to share informationthats gatekeeping in my book.

Solace, which launched in December 2019, is quite unlike any of the other trans-specific apps available through Apples App Store. Searching for trans or transgender on my iPhone turns up an endless scroll of dating apps for cis men trying to meet trans women and crossdressers with nearly illegibile, knockoff brand names like Tinded, Sinder, and Transdr. Theyre mostly godawful, Anthony said. Fetishizing trans people... transsexual dating dot this, and stuff. There are a few practical options that actually seem to have been designed with a trans user in mind, like audio recording apps to practice voice modification, crowdsourced safe restroom finders, and a selfie-driven transition tracker. But nothing is quite as comprehensive as Solace, which contains more than 180,000 words of text, according to Anthonys estimate.

The app gives users the ability to curate a custom checklist of transition tasks, which are divided into three categories: legal (updating your birth certificate, what you can do about workplace discrimination); lifestyle (coming out to your family, connecting with other trans people); and medical (facial feminization surgery, laser hair removal, family planning). Every item is comprehensive, containing lots of actionable information about the task at hand. The coming out to family entry, for example, includes both tips on what to do (write a coming out letter to each and every family member, ask to be called by your name and pronouns, be ready to explain what transgender means) along with general advice (make sure you are sober when you come out, be prepared to lose your housing or financial support).

Many of the resources are tailored to the users gender identity and location, as non-discrimination laws and the legal hoops one has to hop through in order to change the name and gender marker on their state-issued documents vary by state. For example, the page for updating your birth certificate in Arizona correctly notes that youll need an affidavit, a certified copy of a court order, a photo copy of a valid government-issued ID, a signed letter from your physician verifying that youve undergone a sex change operation, and a small fee. The page for Washington is significantly shorter, as the Evergreen State doesnt require surgery or a fee.

Solace is free to download and the creators have no intention of selling user data to third parties. We will never charge a penny, Anthony said. Were currently donor supported. We tap into foundation support, sometimes as grants. Were structured as a nonprofit. This community faces a disproportionate amount of poverty, so putting a paywall on this thing felt counterintuitive to what we were trying to do. And data-mining, she paused. Our stomachs turn at the thought of it.

Anthony declined to share how many people have downloaded Solace since launch, though she said she and McHugh are currently halfway to reaching their 2020 user goal. The app has had a number of updates since its December launch, like the addition of more detailed information regarding Medicaid coverage for trans care in different parts of the country. Anthony said that she also plans to integrate a news aggregator with articles about a variety of trans topics, implement dynamic pronouns within the apps copyto match the pronouns the user enters, and launch a mode for parents and guardians of trans kids.

Listening to Anthony talk, I couldnt help but think about how different my experience with transitioning has been. Its not that I havent had to seek out other trans people to find out who they see for laser hair removal or whether progesterones really worth the hype; Ive had to do all of those things. The difference is that I view them as positives rather than negatives. Ive found a lot of value in talking to other trans people about their experiences and sifting through their anecdotal experiences to figure out what might be right for me. Im deeply grateful for all the friendships Ive made and communities Ive joined after putting myself in uncomfortable, new social situations. I asked Anthony if she was concerned that an app like Solace might lead trans people away from their local communities. Its a byproduct were aware of, she said, but I wouldnt say that its a goal of ours.

Our entire ethos is about providing this community with agency, and part of agency is allowing people to access information on their own terms, she said.

Solace might not be of that much use to me, an extrovert in a major city whos already in community with other trans people (and my questions at this point of my transition are more existential than they are practicalless about how do I do this or how do I do that, and more about what do I do now). But it could be useful to people who dont know any trans people, or live in a part of the country with no visible local community, and might be particularly helpful for early transitioners or trans people who havent come out yet and are still trying to figure out where to begin.

Regardless of who makes use of Solaces many comprehensive resources, Anthony was clear about one thing: she doesnt want anyone to rely on the app forever. The ultimate sign of Solaces success is that the user deletes the app because they dont need it anymore, she said.

Sign up for our newsletter to get the best of VICE delivered to your inbox daily.

Follow Harron Walker on Twitter .

Original post:
Want to Transition? There's an App for That - VICE

Posted in Hormone Replacement Therapy | Comments Off on Want to Transition? There’s an App for That – VICE

Anti-Osteoporosis Therapy And Fracture Healing Market : Trends and Future Applications – News Times

Posted: February 27, 2020 at 8:42 am

Anti-Osteoporosis Therapy And Fracture Healing Market (2018) Report Provides an in-depth summary of Anti-Osteoporosis Therapy And Fracture Healing Market Status as well as Product Specification, Technology Development, and Key Manufacturers. The Report Gives Detail Analysis on Market concern Like Anti-Osteoporosis Therapy And Fracture Healing Market share, CAGR Status, Market demand and up to date Market Trends with key Market segments.

The latest report about the Anti-Osteoporosis Therapy And Fracture Healing market provides a detailed evaluation of the business vertical in question, alongside a brief overview of the industry segments. An exceptionally workable estimation of the present industry scenario has been delivered in the study, and the Anti-Osteoporosis Therapy And Fracture Healing market size with regards to the revenue and volume have also been mentioned. In general, the research report is a compilation of key data with regards to the competitive landscape of this vertical and the multiple regions where the business has successfully established its position.

Request Sample Report @ https://www.marketresearchhub.us/enquiry.php?type=S&repid=2525076&source=atm

Leading manufacturers of Anti-Osteoporosis Therapy And Fracture Healing Market:

The following manufacturers are covered:NovartisJohnson and JohnsonGlaxoSmithKline PLCRochePfizerMERCKAMGEN

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeBisphosphonatesCalcitoninEstrogen or Hormone Replacement TherapyBiologicsAnabolics

Segment by ApplicationHospital PharmaciesPrivate ClinicsDrug StoresRetail PharmaciesE-Commerce

Make An EnquiryAbout This Report @ https://www.marketresearchhub.us/enquiry.php?type=E&repid=2525076&source=atm

Scope of The Anti-Osteoporosis Therapy And Fracture Healing Market Report:

This research report for Anti-Osteoporosis Therapy And Fracture Healing Market explores different topics such as product scope, product market by end users or application, product market by region, the market size for the specific product Type, sales and revenue by region forecast the Market size for various segments. The Report provides detailed information regarding the Major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Anti-Osteoporosis Therapy And Fracture Healing market. The Anti-Osteoporosis Therapy And Fracture Healing Market Report analyzes opportunities in the overall Anti-Osteoporosis Therapy And Fracture Healing market for stakeholders by identifying the high-growth segments.

A detailed overview of the geographical and competitive sphere of the Anti-Osteoporosis Therapy And Fracture Healing market:

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2525076&licType=S&source=atm

Table of Content of The Report

Chapter 1- Anti-Osteoporosis Therapy And Fracture Healing Industry Overview:

1.1 Definition of Anti-Osteoporosis Therapy And Fracture Healing

1.2 Brief Introduction of Major Classifications

1.3 Brief Introduction of Major Applications

1.4 Brief Introduction of Major Regions

Chapter 2- Production Market Analysis:

2.1 Global Production Market Analysis

2.1.1 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

2.1.2 Major Manufacturers Performance and Market Share

2.2 Regional Production Market Analysis

Chapter 3- Sales Market Analysis:

3.1 Global Sales Market Analysis

3.2 Regional Sales Market Analysis

Chapter 4- Consumption Market Analysis:

4.1 Global Consumption Market Analysis

4.2 Regional Consumption Market Analysis

Chapter 5- Production, Sales and Consumption Market Comparison Analysis

Chapter 6- Major Manufacturers Production and Sales Market Comparison Analysis

Chapter 7- Major Classification Analysis

Chapter 8- Major Application Analysis

Chapter 9- Industry Chain Analysis:

9.1 Up Stream Industries Analysis

9.2 Manufacturing Analysis

The rest is here:
Anti-Osteoporosis Therapy And Fracture Healing Market : Trends and Future Applications - News Times

Posted in Hormone Replacement Therapy | Comments Off on Anti-Osteoporosis Therapy And Fracture Healing Market : Trends and Future Applications – News Times

Global Hormone Replacement Therapy Market 2025 Forecasts and Analysis with Top Key Players like – Merck Serono, Novo Nordisk, Eli Lilly – Fashion…

Posted: February 27, 2020 at 8:42 am

Eon Market Research currently generated a research report titled, Global Hormone Replacement Therapy Market Research Report 2020. The studies report represents the ability growth opportunities that prevail within the worldwide market.The document is analyzed on the idea of secondary research methodologies acquired from historic and forecast data. The global Hormone Replacement Therapy marketplace is predicted to grow significantly and thrive in terms of quantity and price all through the forecast period. The record will provide an perception approximately the growth possibilities and restraints that construct the marketplace. Readers can benefit significant comprehension approximately the destiny of the marketplace.

The report includes top key players and manufacturers operating inside the local and global market. This segment demonstrates the techniques adopted by way of players in the market to stay ahead in the competition. New tendencies and its adoption with the aid of players help readers recognize the dynamics of the enterprise and how it may be used to their own profit. The readers also can pick out the footsteps of players to recognize the worldwide market better.

For Better Understanding, Download Free Sample PDF Hormone Replacement Therapy Market Research Report @https://www.eonmarketresearch.com/sample/56636

Leading Players Are:

PfizerMerck SeronoNovo NordiskEli LillyBayer HealthcareNovartis

Buy This Premium Report @ https://www.eonmarketresearch.com/buy/56636

Global Hormone Replacement Therapy Market Segmentation:

By Type:

Estrogen Replacement TherapyThyroid Replacement Therapy

By Application:

OralParenteralTransdermal

Place An Inquiry Before Buying @ https://www.eonmarketresearch.com/enquiry/53386

Analysis of Hormone Replacement Therapy market(Historical Data, Current, and Forecast) to analyze the ratio of growth and Hormone Replacement Therapy market size.

Hormone Replacement Therapy Market risk, market opportunities, growth-driving forces, and confining factors of the business.

It provides a transparent research plan regarding the Hormone Replacement Therapy existing competitors together with rising ones.

New technologies and issues to investigate Hormone Replacement Therapy market dynamics.

Hormone Replacement Therapy Market Forecast from 2020 to 2025.

Closely evaluate Hormone Replacement Therapy latest and developing market segments.

Hormone Replacement Therapy Market investigation with relevancy Hormone Replacement Therapy business value and volume.

Totally various strategies and approaches employed by competitors to reinforce growth in Hormone Replacement Therapy Market.

About Us:

Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our specific combo of quantitative forecasting and trends analysis offers forward-searching insight for heaps of decision-makers.

Contact Us:

Eon Market ResearchPhone: +1 703 879 7090Email: sales@eonmarketresearch.com

Read the original here:
Global Hormone Replacement Therapy Market 2025 Forecasts and Analysis with Top Key Players like - Merck Serono, Novo Nordisk, Eli Lilly - Fashion...

Posted in Hormone Replacement Therapy | Comments Off on Global Hormone Replacement Therapy Market 2025 Forecasts and Analysis with Top Key Players like – Merck Serono, Novo Nordisk, Eli Lilly – Fashion…

American College of Rheumatology Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases – Myers Messenger

Posted: February 27, 2020 at 8:42 am

ATLANTA, Feb. 24, 2020 (GLOBE NEWSWIRE) Today, the American College of Rheumatology (ACR) published the . This is the first, evidence-based, clinical practice guideline related to the management of reproductive health issues for all patients with rheumatic diseases. With 131 recommendations, the guideline offers general precepts that provide a foundation for its recommendations and good practice statements.

This guideline is paramount, because it is the first official guidance addressing the intersection of rheumatology and obstetrics and gynecology (OB-GYN), said Lisa Sammaritano, MD, lead author of the guideline. Rheumatic diseases affect many younger individuals; however, little education has been provided to rheumatology professionals on current OB-GYN practices. The guideline [and more detailed ] presents vital background knowledge and recommendations for addressing reproductive health issues in the full spectrum of rheumatology patients, with additional focus on specific diagnoses that require more detailed recommendations such as (SLE) and (APS).

The guideline provides 12 ungraded good practice statements and 131 graded recommendations that are intended to guide care for rheumatology patients except where indicated as being for patients with specific conditions or antibodies present. Good practice statements are those in which indirect evidence is compelling enough that a formal vote was considered unnecessary; these are ungraded and are presented as suggestions rather than formal recommendations. The recommendations were separated into six categories: contraception, assisted reproductive technology (fertility therapies), fertility preservation with gonadotoxic therapy, menopausal hormone replacement therapy, pregnancy assessment and management, and medication use.

While some of the recommendations are strong, many of the recommendations presented are conditional due to a lack of data. Pregnant women are not generally enrolled in clinical studies; and few maternal health studies focus on rheumatology patients. A few notable recommendations from each category include:

Contraception

Strong recommendation for women with rheumatic disease who do not have lupus or APS to use effective contraceptives with a conditional recommendation to preferentially use highly effective IUDs or a subdermal progestin implant.

Strong recommendation against using combined estrogen-progestin contraceptives in women who test positive for anti-phospholipid autoantibodies (aPL) or APS.

Assisted Reproductive Technology (Fertility Therapies)

Strong recommendation for fertility therapy in women with uncomplicated rheumatic disease who are receiving pregnancy-compatible medications, whose disease is stable, and who test negative for aPL. Specific recommendations also address patients testing positive for aPL and suggest an anti-blood clotting procedure.

Conditional recommendation against increasing prednisone dosage during fertility therapy procedures in lupus patients.

Fertility Preservation

Conditional recommendation against testosterone co-therapy in men with rheumatic disease receiving cyclophosphamide (CYC) and a good practice suggestion to cryopreserve sperm before CYC treatment in men who desire it.

Conditional recommendation for monthly gonadotropin-releasing hormone agonist co-therapy for premenopausal women with rheumatic disease who are receiving monthly CYC injections/infusions to prevent premature ovarian insufficiency.

Pregnancy Assessment and Management

Strong good practice suggestion to counsel women with rheumatic disease, who are considering pregnancy, on the improved maternal and fetal outcomes associated with entering pregnancy during low disease activity.

Conditional recommendation to treat lupus patients with low-dose aspirin daily (81 to 100 mg) starting in the first trimester. For women testing positive for aPL who do not meet the criteria for obstetric or thrombotic APS, it is conditionally recommended to preventatively treat with a daily aspirin (81 to 100 mg) starting early in pregnancy and continuing through delivery.

Menopause and Hormone Replacement Therapy

A good practice suggestion to use hormone replacement therapy in postmenopausal women with rheumatic disease who do not have lupus or have a positive aPL test; and who have severe vasomotor symptoms, have no contraindications, and desire treatment.

A conditional recommendation for hormone replacement therapy in women with lupus and without aPL.

Conditionally recommend against treating with hormone replacement therapy for women with asymptomatic aPL, and strongly recommend against hormone replacement therapy for women with any form of APS.

Medication Use (Paternal and Maternal)

Strongly recommend against use of CYC and thalidomide in men prior to attempting conception.

Strong recommendation against the use of NSAIDs in the third trimester.

Individuals involved in the development of the new guideline included rheumatologists, obstetrician/gynecologists, reproductive medicine specialists, epidemiologists, and patients with rheumatic diseases. ACR guidelines are currently developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, which creates rigorous standards for judging the quality of the literature available and assigns strengths to the recommendations that are largely based on the quality of the available evidence.

This guideline should open avenues of communication between the rheumatologist and the patient, as well as between the rheumatologist and the OB-GYN, said Dr. Sammaritano. A better understanding of the risks and benefits of reproductive health options will enhance patient care by providing safe and effective contraception, improving pregnancy outcomes by conceiving during inactive disease periods, and allowing for continued control of rheumatic diseases during and after pregnancy with the use of well-suited medications.

A draft of the guideline was presented during the 2018 ACR/ARP Annual Meeting in Chicago. Since that time, the guideline team has condensed the original three-part draft into a single, concise manuscript, with detailed background and discussion now available . The guideline development team also incorporated color-coded flow charts to highlight common decision-making points to make it user friendly.

The paper containing the full list of recommendations and supporting evidence is available at

###

About the American College of Rheumatology The American College of Rheumatology (ACR) is an international medical society representing over 8,500 rheumatologists and rheumatology health professionals with a mission to empower rheumatology professionals to excel in their specialty. In doing so, the ACR offers education, research, advocacy and practice management support to help its members continue their innovative work and provide quality patient care. Rheumatologists are experts in the diagnosis, management and treatment of more than 100 different types of arthritis and rheumatic diseases. For more information, visit .

Monica McDonald American College of Rheumatology ext. 332 mmcdonald.org

Read the original:
American College of Rheumatology Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases - Myers Messenger

Posted in Hormone Replacement Therapy | Comments Off on American College of Rheumatology Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases – Myers Messenger

Cumberland County family turns to non-FDA approved stem cell treatment to help two-year-old son with cerebral palsy – FOX43.com

Posted: February 27, 2020 at 8:41 am

Lance was diagnosed with cerebral palsy a year ago. His family hopes non-FDA approved stem cell treatment for the disease can help him walk and talk.

CAMP HILL, Pa. A family in Cumberland County has turned to stem cells to treat their two-year-old son diagnosed with cerebral palsy. The only problem: stem cell treatment for the disease hasn't been approved by the FDA.

The day he was born, when he wheeled him down the hall and he was only a pound, and I started to cry and said, will he live? And he said, of course Hes only small," said Danielle Maxwell, Lance's mom.

The words, "he's only small," are what Lance's mom and father Rob have lived by since the day he was born. The preemie, born three months early, has been through several surgeries and complications along the way. But, Lance has always been a fighter.

Lance fought so hard just to survive the beginning of life, and come home with us," said Danielle. "And he is just so happy and loving and amazing.

About a year ago, Lance was diagnosed with cerebral palsy. Doctors told his family, he will never walk, talk or take care of himself.

We just dont believe that," said Danielle. "We dont.

Lance receives a lot of different therapies but, his parents did not want to just stop there.

We both overwhelmingly feel, he never gave up, he never gave up on us, he never gave up on himself," said Rob. "So, we owe it to him to give him the opportunity. Its really that simple, he deserves the opportunity."

Danielle began researching stem cell therapies, even speaking to doctors in countries overseas where treatment with stem cells is more readily accessible than in the U.S. The FDA has approved stem cell treatments for some conditions but not cerebral palsy. However, trials to determine the effectiveness of stem cell treatment for the disease are underway.

What weve seen is a small but real appearing improvement in motor function," said Doctor Charles Cox with University of Texas Health in Houston, began a trial in 2013 on the safety and effectiveness of banked cord blood or bone marrow stem cells in children with cerebral palsy, and is now just wrapping up the results from the trial.

The overall results of this study depend if youre a glass half full or half empty kind of person," said Dr. Cox. "It is not a compelling miraculous result. Its not, Oh my God, this child was treated and look at this profound benefit.'"

Because stem cell treatment for cerebral palsy is still in trial phases, it's not approved treatment by the FDA. However, the Maxwells did find a doctor in Harrisburg willing to transfer stem cells from a full-term baby's umbilical cord to Lance. But, since it isn't FDA approved, we were not allowed to be there to show Lance receiving the stem cells. The Maxwells are hopeful following this procedure Lance may someday walk and more importantly be able to communicate with them.

He wants to be involved," said Rob. "You can tell hes trying to communicate he just cant get over that hump. We believe stem cells could be that bridge to help him move a little faster.

Danielle says, it will take about six months to see if the stem cells will have any definitive benefits for Lance. But, already says she's seeing progress. She says Lance is not able to stand on his own.

Read this article:
Cumberland County family turns to non-FDA approved stem cell treatment to help two-year-old son with cerebral palsy - FOX43.com

Posted in Texas Stem Cells | Comments Off on Cumberland County family turns to non-FDA approved stem cell treatment to help two-year-old son with cerebral palsy – FOX43.com

Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and…

Posted: February 27, 2020 at 8:41 am

St. Paul, MN, February 27, 2020 --(PR.com)-- Recombinetics (RCI) today announced a collaborative research project with University of Texas Southwestern (UTSW) to identify key factors that improve the efficiency of generating interspecies chimera between pigs and humans. This near-term goal will benefit the long-term objective of advancing regenerative medicine through the reliable production of therapeutic human cells, tissues and organs using blastocyst complementation. This would create a more reliable supply of live-saving transplantable organs on demand that is not reliant on human donors.

This collaboration will leverage the expertise of RCI in producing inter-species chimeras, specifically using the blastocyst complementation method, where the host species is mutated to ablate a crucial organ or lineage, and the human donor cells are populating the missing niche. Our plan is to understand the relationship between human and pig cells through development and utilize gene editing to improve the survival, engraftment and differentiation of the donor human cells in the specific niche. These technologies could very well hold the crucial step that move us towards producing human components in bio-incubators.

Project efforts will be led by Ohad Gafni, Ph.D., RCIs Director of Stem Cell Technologies and Jun Wu, Ph.D., Assistant Professor at UT Southwestern Medical Center.

Scientists have struggled to produce inter species chimera due to poor survival and engraftment of the injected donor cells in the host environment. In this collaboration, we will combine in vitro and in vivo studies to enhance the efficiency of producing pig: human chimeras as a foundation for producing therapeutic human cells, tissues, and organs, says Dr. Gafni.

About RecombineticsFounded in 2008, Recombinetics (RCI) is producing gene-edited animals for biomedical and food production purposes and is generating commercial and collaborative revenues. RCIs technology platform supports three business lines: Acceligen (precision breeding to enhance health, well-being and productivity in food animals and aquaculture); Surrogen (gene-edited swine models of human diseases for biomedical research and pre-clinical trials by pharmaceutical and medical device companies); and Regenevida (development of human regenerative products including cells, tissues and organ products in swine models for exotransplantation to humans). Learn more at Recombinetics.com.

View original post here:
Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and...

Posted in Texas Stem Cells | Comments Off on Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and…

Circulating Tumor Cells and Cancer Stem Cells Market: Quantitative Analysis from 2019 to 2025 to Enable the Stakeholders to Capitalize on the…

Posted: February 25, 2020 at 10:45 pm

In this new business intelligence Circulating Tumor Cells and Cancer Stem Cells market report, PMR serves a platter of market forecast, structure, potential, and socioeconomic impacts associated with the global Circulating Tumor Cells and Cancer Stem Cells market. With Porters Five Forces and DROT analyses, the research study incorporates a comprehensive evaluation of the positive and negative factors, as well as the opportunities regarding the Circulating Tumor Cells and Cancer Stem Cells market.

With having published myriads of Circulating Tumor Cells and Cancer Stem Cells market reports, PMR imparts its stalwartness to clients existing all over the globe. Our dedicated team of experts deliver reports with accurate data extracted from trusted sources. We ride the wave of digitalization facilitate clients with the changing trends in various industries, regions and consumers. As customer satisfaction is our top priority, our analysts are available 24/7 to provide tailored business solutions to the clients.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/13306

The Circulating Tumor Cells and Cancer Stem Cells market report has been fragmented into important regions that showcase worthwhile growth to the vendors Region 1 (Country 1, Country 2), region 2 (Country 1, Country 2) and region 3 (Country 1, Country 2). Each geographic segment has been assessed based on supply-demand status, distribution, and pricing. Further, the study provides information about the local distributors with which the Circulating Tumor Cells and Cancer Stem Cells market players could create collaborations in a bid to sustain production footprint.

key participants are expanding the market by developing the facilities in different regions. For example, in September 2014 advanced cell diagnostic Inc. established a subsidiary in Europe to serve the European market.

The report covers exhaustive analysis on:

Regional analysis includes

Report Highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/13306

What does the Circulating Tumor Cells and Cancer Stem Cells market report contain?

Readers can get the answers of the following questions while going through the Circulating Tumor Cells and Cancer Stem Cells market report:

And many more

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/13306

About us:

PMR is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact us:

305 Broadway, 7th Floor

New York City, NY 10007

United States

Ph.no. +1-646-568-7751

See the original post here:
Circulating Tumor Cells and Cancer Stem Cells Market: Quantitative Analysis from 2019 to 2025 to Enable the Stakeholders to Capitalize on the...

Posted in New York Stem Cells | Comments Off on Circulating Tumor Cells and Cancer Stem Cells Market: Quantitative Analysis from 2019 to 2025 to Enable the Stakeholders to Capitalize on the…

Doctors Are Injecting This Naturally-Derived Substance to Restore Hair Thicknessand Its Not PRP – NewBeauty Magazine

Posted: February 25, 2020 at 10:45 pm

The most emotional issue my patients have is hair loss, says New York dermatologist Cheryl Karcher, MD below a jaw-dropping before-and-after photo shared to her Instagram page. On the left half of the photo shared is a young womans exposed hairlinethe hair is so thin and sparse, the entire scalp is visible wherever your eye is drawn. On the right side of the photo, the same woman, but with an almost unbelievable amount of thicker hair, and, somehow, a sense of renewed confidence.

The secret? A little thing called nanofat.

In the past we only had PRP to offer that had to be done three times or more. Sometimes it would work, sometimes it didnt. Now we have nanofat hair restoration, which needs to be done just once, and is much more effective way to treat hair loss and grow hair, explains Dr. Karcher.

You May Also Like: How Low Level Laser Therapy Actually Works to Thicken Hair

So what is nanofat? According to Dr. Karcher, its derived from our own adipose tissue, whereas the ever popular PRP is derived from our blood. Nanofat includes adipose-derived stromal vascular fraction, which contains stem cells as well as growth factors. PRP contains the growth factors released from platelets in the blood, she adds. The procedure itself involves extracting anywhere from 20 to 40 millilitersof fat, usually from the abdomen, then processing it through mechanical filters, before injecting.

Like PRP, the possibilities of what nanofat can help with doesnt stop at the hairline. After the nanofat is processed to the point where there is no fat left, only stem cells and growth factors, it is injected into the scalp, the face, the neck, the decollete, or to improve sun damage, skin pigmentation, decrease wrinkles, and of course grow hair, says Dr. Karcher.

When nanofat is used for hair restoration, Dr. Karcher says she first injects the nanofat, then injects the patients PRP on top of it to act as a fertilizer for the nanofat. Perhaps the best part? Theres little to no painDr. Karcher says the most pain patients feel is during the PRP injections, so the scalp is numbed topicallyand no downtime. When nanofat is used on the face, chest or other areas, Dr. Karcher warns there may be some downtime of erythema and swelling or bruising. If injected for [skin] rejuvenation via microneedling the downtime is only about 48 hours.

While Dr. Karcher has seen unparalleled results from nanofat hair restoration, it is only ideal for patients who have some hair still present on the scalppatients who are completely bald may not be ideal candidates for the procedure. The only time I ever use PRP for hair restoration now is in a patient that doesnt have enough fat to harvest. The nanofat is just one treatment and the results seem to be superior. However, as La Jolla, CA plastic surgeon Robert Singer, MD notes, there is no safety or efficacy data surrounding nanofat treatment as of press time.

Sign up to receive our newsletter

See more here:
Doctors Are Injecting This Naturally-Derived Substance to Restore Hair Thicknessand Its Not PRP - NewBeauty Magazine

Posted in New York Stem Cells | Comments Off on Doctors Are Injecting This Naturally-Derived Substance to Restore Hair Thicknessand Its Not PRP – NewBeauty Magazine

Succeeding in the 2020 Europe Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence,…

Posted: February 25, 2020 at 10:45 pm

New York, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Succeeding in the 2020 Europe Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers" - https://www.reportlinker.com/p05861931/?utm_source=GNW

Rationale

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

Companies Profiled Competitive Assessments

- Abbott - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - CellaVision - Horiba - Nihon Kohden - Ortho-Clinical Diagnostics - Roche - Siemens Healthineers - SysmexRead the full report: https://www.reportlinker.com/p05861931/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Follow this link:
Succeeding in the 2020 Europe Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence,...

Posted in New York Stem Cells | Comments Off on Succeeding in the 2020 Europe Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence,…

Page 1,117«..1020..1,1161,1171,1181,119..1,1301,140..»